ESLA
Price
$1.09
Change
+$0.14 (+14.74%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
35.88M
Intraday BUY SELL Signals
PRQR
Price
$1.65
Change
+$0.01 (+0.61%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
172.77M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ESLA vs PRQR

Header iconESLA vs PRQR Comparison
Open Charts ESLA vs PRQRBanner chart's image
Estrella Immunopharma
Price$1.09
Change+$0.14 (+14.74%)
Volume$1.24K
Capitalization35.88M
ProQR Therapeutics
Price$1.65
Change+$0.01 (+0.61%)
Volume$5.03K
Capitalization172.77M
ESLA vs PRQR Comparison Chart in %
ESLA
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ESLA vs. PRQR commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLA is a Hold and PRQR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ESLA: $1.04 vs. PRQR: $1.64)
Brand notoriety: ESLA and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ESLA: 35% vs. PRQR: 114%
Market capitalization -- ESLA: $41.16M vs. PRQR: $172.77M
ESLA [@Biotechnology] is valued at $41.16M. PRQR’s [@Biotechnology] market capitalization is $172.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLA’s FA Score shows that 0 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • ESLA’s FA Score: 0 green, 5 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, PRQR is a better buy in the long-term than ESLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLA’s TA Score shows that 4 TA indicator(s) are bullish while PRQR’s TA Score has 4 bullish TA indicator(s).

  • ESLA’s TA Score: 4 bullish, 5 bearish.
  • PRQR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ESLA and PRQR are a bad buy in the short-term.

Price Growth

ESLA (@Biotechnology) experienced а -27.78% price change this week, while PRQR (@Biotechnology) price change was -24.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

PRQR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($173M) has a higher market cap than ESLA($35.9M). PRQR YTD gains are higher at: -18.812 vs. ESLA (-39.096). ESLA has higher annual earnings (EBITDA): -8.82M vs. PRQR (-38.15M). PRQR has more cash in the bank: 107M vs. ESLA (1.63M). PRQR has higher revenues than ESLA: PRQR (15.5M) vs ESLA (0).
ESLAPRQRESLA / PRQR
Capitalization35.9M173M21%
EBITDA-8.82M-38.15M23%
Gain YTD-39.096-18.812208%
P/E RatioN/AN/A-
Revenue015.5M-
Total Cash1.63M107M2%
Total DebtN/A16.5M-
FUNDAMENTALS RATINGS
PRQR: Fundamental Ratings
PRQR
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ESLAPRQR
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ESLA
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYFL47.000.74
+1.60%
Century Financial Corp.
CMPD4.36N/A
N/A
CompuMed, Inc.
CVHSY5.05N/A
N/A
CABLEVISION HLDGS SA
XYIGY21.39N/A
N/A
Xinyi Glass Holdings Ltd.
EPOAY24.12-0.57
-2.31%
Epiroc Aktiebolag

ESLA and

Correlation & Price change

A.I.dvisor tells us that ESLA and PRQR have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and PRQR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
-10.37%
PRQR - ESLA
25%
Poorly correlated
-2.38%
CRIS - ESLA
24%
Poorly correlated
-2.03%
PRLD - ESLA
24%
Poorly correlated
+1.82%
TERN - ESLA
24%
Poorly correlated
+1.00%
CYTOF - ESLA
23%
Poorly correlated
N/A
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with RGNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-2.38%
RGNX - PRQR
49%
Loosely correlated
-0.20%
BEAM - PRQR
46%
Loosely correlated
+2.55%
RNAC - PRQR
44%
Loosely correlated
+5.36%
ETHZ - PRQR
44%
Loosely correlated
+3.62%
DNLI - PRQR
44%
Loosely correlated
+0.89%
More